Search clinical trials for: Normal ovarian reserve

Total 14160 results

RenJi Hospital

Recruiting

Sodium Valproate in Patients With Acute Ischemic Stroke

Acute Ischemic Stroke

China
National Cancer Institute (NCI)
NRG Oncology

Recruiting

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

Ovarian Endometrioid Adenocarcinoma | Endometrial Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Endometrioid Adenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian High Grade Serous Adenocarcinoma | Platinum-Resistant Ovarian Carcinoma | Endometrial Low Grade Endometrioid... and other conditions

United States
Ahmed Saad
Hawaa Fertility Center

Not yet recruiting

Ovarian Injection of PRP (Platelet -Rich Plasma) Vs Normal Saline in Premature Ovarian Insufficiency

Premature Ovarian Failure

Egypt
Shandong University of Traditional Chinese Medicine

Recruiting

Efficacy and Safety of Gushen Antai Pill on Ongoing Pregnancy Rate in Women With Normal Ovarian Reserve Undergoing IVF-ET (GSATP-FreET)

Infertility, Female

China
National Cancer Institute (NCI)

Recruiting

Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors

Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Recurrent Platinum-Resistant Ovarian Carcinoma | Refractory Ovarian Carcinoma

United States
National Cancer Institute (NCI)
NRG Oncology

Active, not recruiting

Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone

Endometrial Mixed Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Stage IV Uterine Corpus Cancer AJCC v8 | Endometrial Adenocarcinoma | Endometrioid Adenocarcinoma

United States, Canada
National Cancer Institute (NCI)
NRG Oncology

Active, not recruiting

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer

Endometrial Endometrioid Adenocarcinoma | Stage I Uterine Corpus Cancer AJCC v8 | Stage II Uterine Corpus Cancer AJCC v8

United States, Puerto Rico
National Cancer Institute (NCI)
NRG Oncology

Active, not recruiting

Nivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
National Cancer Institute (NCI)
NRG Oncology

Active, not recruiting

Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Fallopian Tube Mucinous Adenocarcinoma and other conditions

United States, Korea, Republic of, Canada
National Cancer Institute (NCI)
NRG Oncology

Active, not recruiting

Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Stage IA Fallopian Tube Cancer AJCC v6 and v7 | Stage IA Ovarian Cancer AJCC v6 and v7 | Stage IB Fallopian Tube Cancer AJCC v6 and v7 | Stage IB Ovarian Cancer AJCC v6 and v7 | Stage IC Fallopian Tube Cancer AJCC v6 and v7 | Stage... and other conditions

United States
ETOP IBCSG Partners Foundation
National Cancer Institute (NCI); NCIC Clinical Trials Group; Cancer and Leukemia... and other collaborators

Active, not recruiting

Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer (SOFT)

Recurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive Tumor

United States, Canada, Switzerland
GOG Foundation
National Cancer Institute (NCI)

Active, not recruiting

Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer

Recurrent Endometrial Clear Cell Adenocarcinoma | Recurrent Endometrial Endometrioid Adenocarcinoma | Recurrent Endometrial Serous Adenocarcinoma | Recurrent Endometrial Undifferentiated Carcinoma | Recurrent Uterine Corpus Cancer | Endometrial Mucinous Adenocarcinoma | Endometrial Squamous Cell... and other conditions

United States, Canada
GOG Foundation
National Cancer Institute (NCI)

Active, not recruiting

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

Uterine Carcinosarcoma | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Mixed Mesodermal (Mullerian) Tumor | Stage I Ovarian Cancer AJCC v6 and v7 | Stage IA Fallopian Tube Cancer AJCC v6 and v7 | Stage IA Ovarian Cancer AJCC v6 and v7 | Stage... and other conditions

United States, Korea, Republic of
National Cancer Institute (NCI)
NRG Oncology

Completed

Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Clear Cell Adenocarcinoma and other conditions

United States
National Cancer Institute (NCI)
NRG Oncology

Completed

Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Ovarian Endometrioid Adenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Fallopian Tube Mucinous... and other conditions

United States, Korea, Republic of, Canada, Japan
Bundang CHA Hospital

Unknown

Melatonin Study Between Diminished and Normal Responder in IVF

Infertility, Female

Korea, Republic of
Sixth Affiliated Hospital, Sun Yat-sen University

Unknown

Fertility and Ovarian Reserve Function in the Patient With Inflammatory Bowel Disease

Fertility Disorders | Pregnancy Outcomes | Ovarian Reserve Function

China
The University of Hong Kong

Completed

Use of Dehydroepiandrosterone (DHEA) in Women With Normal and Poor Ovarian Reserve Undergoing IVF

Female Infertility Due to Diminished Ovarian Reserve

Hong Kong
Peking University Third Hospital

Recruiting

The Effeciency of NMN in Improving IVF/ICSI-ET Pregnancy Outcomes in Patients With DOR

Diminished Ovarian Reserve

China
Beni-Suef University

Not yet recruiting

of Myo-inositol, Melatonin and Co-enzyme q10 on Ovarian Reserve

IVF

Egypt
Xiaomei Shao
Hangzhou Hospital of Traditional Chinese Medicine

Recruiting

Study of Acupoints in Diminished Ovarian Reserve Based on Biological Characteristics

Diminished Ovarian Reserve

China
Yun Chen

Recruiting

Real-world Evaluation of Qingxin Zishen Decoction on Ovarian Reserve Function Clinical Efficacy in Patients With Decreased

Decreased Ovarian Reserve

China
IRCCS Burlo Garofolo

Recruiting

Role of Preoperative D-dimer Levels in the Diagnosis of Adnexal Torsion

Adnexal Torsion

Italy
National University of Malaysia

Recruiting

GREM1, HAS2 and PTGS2 Gene Expression Following the in Vitro Maturation (IVM)

in Vitro Maturation | Cumulus Cell | Increased Oocyte Death | GREM1 Gene Mutation

Malaysia
Jagiellonian University

Recruiting

Activity of Chronic Inflammation in PCOS

Polycystic Ovary Syndrome

Poland
Xiaomei Shao
Hangzhou Hospital of Traditional Chinese Medicine

Recruiting

Efficacy of Thumb-tack Needle Treatment for Diminished Ovarian Reserve

Diminished Ovarian Reserve

China
Second Affiliated Hospital, School of Medicine,...
The First Affiliated Hospital of Nanchang University; Seoul St. Mary's Hospital and other collaborators

Not yet recruiting

FFR Versus IVUS With Angiography-Derived FFR for Clinical Outcomes in Patients With Coronary Artery Disease (FLAVOUR III)

Coronary Artery Disease

Korea, Republic of, China
Shi Yun

Recruiting

the Correlation Between Ovarian Function and Serum Biomarkers

Aging | Diminished Ovarian Reserve | Biomarker | Premature Ovarian Insufficiency | Copper | Ceruloplasmin

China
Women's Hospital School Of Medicine Zhejiang University

Not yet recruiting

The Effect of "KB-120" Small Molecular Nutrient in Women With Decreased Ovarian Reserve

Diminished Ovarian Reserve
Vitti Labs, LLC

Recruiting

A Proof of Concept Study to Evaluate Exosomes From Human Mesenchymal Stem Cells in Women With Premature Ovarian Insufficiency (POI) (VL-POI-01)

Diminished Ovarian Reserve | Premature Ovarian Insufficiency

United States
Beni-Suef University

Not yet recruiting

Platelet Rich Plasma on Ovarian Reserve Parameters and Intra Cytoplasmic Sperm Injection Outcomes in Patients With Diminished Ovarian Reserve

IVF

Egypt
ART Fertility Clinics LLC

Not yet recruiting

Is Decreased Ovarian Reserve Related to an Increased Number of Previous Early Miscarriages?

Miscarriage, Recurrent | Miscarriage | Infertility, Female | IVF

United Arab Emirates
Tam Anh TP. Ho Chi Minh General Hospital
Abbott

Recruiting

DPOS Versus GnRH Antagonist Protocol for Oocyte Accumulation in Low Ovarian Reserve Patients: An RCT (DPOS)

Diminished Ovarian Reserve

Vietnam
Jagiellonian University

Recruiting

Subclinical Hypothyroidism and Chronic Inflammation in PCOS

Subclinical hypothyroïdism | PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries | Hypothalamic-Pituitary-Gonadal Axis Dysfunction

Poland
Aston Sci. Inc.

Not yet recruiting

Adjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian Cancer (Cornerstone4)

Advanced Ovarian Cancer

United States
Generation Next Fertility
Igenomix

Not yet recruiting

Ovarian PRP for Diminished Ovarian Reserve (oPRP)

Diminished Ovarian Reserve
Sixth Affiliated Hospital, Sun Yat-sen University

Not yet recruiting

Etonogestrel Implants Protect Ovarian Reserve Function in Systemic Lupus Erythematosus

Systemic Lupus Erythematosus
Cancer Research UK
Royal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of Birmingham

Recruiting

DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Teenage/Young Adult and Paediatric Patients With Cancers With HER2 Amplification or Activating Mutations (DETERMINE)

Colorectal Neoplasms | Ovarian Neoplasms | Solid Tumor | Gallbladder Neoplasms | Prostatic Neoplasm | Pancreatic Neoplasm | Lung Neoplasm | Haematological Malignancy | Urinary Bladder Neoplasm | Skin Neoplasm | Salivary Gland Neoplasm

United Kingdom
University Hospital, Bordeaux

Recruiting

Study of Ovarian Reserve Concerning Patients With Multiple Sclerosis (MS), Compared to a Control Group (FEMINISEP)

Multiple Sclerosis

France
The First Affiliated Hospital of Hunan University...

Recruiting

Clinical Efficacy of Acupuncture on the Liver Meridian in Women With Diminished Ovarian Reserve (GJZLLCCBGNXJ)

Acupuncture Therapy | Ovarian Reserve | Meridian

China
First Affiliated Hospital Xi'an Jiaotong University

Not yet recruiting

A Multicenter Open-label Clinical Study on the Prevention of Premature Ovarian Failure After HSCT

Hematopoietic Stem Cell Transplantation | Premature Ovarian Failure

China
Tongji Hospital

Recruiting

Precise Stratification of Genetic Risk of Ovarian Function Impairment

Diminished Ovarian Reserve | Premature Ovarian Insufficiency | Early Menopause

China
Celal Bayar University

Recruiting

The Relationship With Mad Honey Containing Grayanotoxin and Ovary Tissue

Ovary Disease

Turkey
University of Valencia
Poznan University of Medical Sciences; Hospital Universitario San Juan de Alicante and other collaborators

Recruiting

Effect of Management of the Endometrioma on Ovarian Reserve (IMTERO)

Endometrioma

Poland, Spain
University Hospital, Lille
Agence Régionale de Santé Hauts de France

Not yet recruiting

Long-term Ovarian Fertility in Patients Treated for Lymphoma. (FERTILymph)

Lymphoma, Follicular
Beni-Suef University

Recruiting

Growth Hormone For Poor Ovarian Reserve Patients in ICSI Trials

Poor Ovarian Reserve

Egypt
Nanjing University

Recruiting

Growth Hormone to Improve the Clinical Outcome of Assisted Fertility in Young Patients With Decreased Ovarian Reserve

Infertility

China
Peking University Third Hospital

Not yet recruiting

Efficacy of Traditional Chinese Medicine on Ameliorating IVF-ET Outcomes of Diminished Ovarian Reserve Patients

Infertility, Female | Diminished Ovarian Reserve
Huazhong University of Science and Technology

Recruiting

Effects of Acupuncture on Ovarian Function and Pregnancy Outcomes in Women With Decreased Ovarian Reserve

Decreased Ovarian Reserve

China
National Cancer Institute (NCI)

Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Anatomic Stage III Breast Cancer AJCC v8 | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Locally Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid... and other conditions

United States, Puerto Rico

Search clinical trials for: Normal ovarian reserve

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations